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ABSTRACT 
 
Background  Exposure to metal working fluid (MWF) has been associated with 
outbreaks of EAA in the US, with bacterial contamination of MWF being a 
possible cause, but was uncommon in the UK.  Twelve workers developed 
extrinsic allergic alveolitis (EAA) in a car engine manufacturing plant in the UK, 
presenting clinically between December 2003 and May 2004. This paper reports 
the subsequent epidemiological investigation of the whole workforce. This had 
three aims:- 
• To measure the extent of the outbreak by identifying other workers who 
may have developed EAA or other work-related respiratory diseases. 
• To provide case-detection so that those affected can be treated.  
• To provide epidemiological data to identify the cause of the outbreak. 
 
Methods  The outbreak was investigated in a three-phase cross-sectional 
survey of the workforce.  
Phase I   A respiratory screening questionnaire was completed by 808/836 
workers (96.7%) in May 2004. 
Phase II   481 employees with at least one respiratory symptom on screening 
and 50 asymptomatic controls were invited for investigation at the factory in 
June 2004. This included a questionnaire, spirometry and clinical opinion.  
454/481(94.4%) responded along with 48/50(96%) controls. Workers were 
identified who needed further investigation and serial measurements of peak 
expiratory flow (PEF).  
Phase III   162 employees were seen at the Birmingham Occupational Lung 
Disease clinic. 198 employees returned PEF records, including 141 of the 162 
who attended for clinical investigation. Case definitions for diagnoses were 
agreed. 
 
Results  87 workers (10.4% of workforce) met case definitions for occupational 
lung disease, comprising EAA(19), occupational asthma(74) and humidifier 
fever(7). 12 workers had more than one diagnosis. The peak onset of work-
related breathlessness was Spring 2003. The proportion of workers affected 
was higher for those using metal working fluid (MWF) from a large sump(27.3%) 
compared with working all over the manufacturing area (7.9%) 
(OR=4.39,p<0.001).  Two workers had positive specific provocation tests to the 
used but not the unused MWF solution. 
 
Conclusions  Extensive investigation of the outbreak of EAA detected a large 
number of affected workers, not only with EAA but also occupational asthma. 
This is the largest reported outbreak in Europe. Mist from used MWF is the 
likely cause. In workplaces using MWF, there is a need to carry out risk 
assessments, to monitor and maintain fluid quality, to control mist and to carry 
out respiratory health surveillance.
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INTRODUCTION 
 
Metal working fluids (MWF) have  been recognised as causing work-related 
respiratory problems since the 1950’s. Initial reports of respiratory effects due to 
the inhalation of oil mists were limited to lipoid pneumonia.[1][2][3]  Case reports 
of occupational asthma due to both clean and used MWF have been 
recorded.[4][5]  Subsequent surveys of MWF exposed workers have found 
respiratory symptoms,[6][7][8][9] often with associated bronchial hyper-
responsiveness,[7] [9] cross-shift changes in lung function,[10][11][12] or 
reduced  lung function.[13] Many of these surveys have been done  in the 
automotive industries. 
 
The first cases of alveolitis due to MWF were reported in the mid 1990’s by 
Bernstein et al in the USA who described six cases of  hypersensitivity 
pneumonitis (extrinsic allergic alveolits).[14] Precipitating antibodies were found 
to a number of microbial isolates the most common being Pseudomonas 
fluorescens. Further outbreaks in the USA have been reported,[15][16][17] with 
several of these outbreaks in the automotive industry.[14][15][16]  Bacterial 
(particularly Mycobacteria) or fungal contamination of MWF are thought to be 
the causes, but no specific agent has fulfilled the criteria for a specific 
cause.[16][17]. 
 
MWF was an uncommon cause of  EAA in the UK before this outbreak with only 
one case being reported to SWORD, the UK national voluntary notification 
scheme, from 1995 to 2002.  Twelve employees from a car engine 
manufacturing plant in England were diagnosed as having EAA, presenting 
clinically to us between December 2003 and May 2004.  Dawkins et al have 
presented the findings from this case series of twelve workers, which showed 
heterogeneous clinical, radiological and pathological findings, but all met the 
case definition for EAA.[18] The factory machined engine parts from aluminium 
alloys or cast iron and assembled car engines. The machining process used 
MWF (oil water emulsions with chemical additives including biocides). During 
use the MWF became contaminated by lubricating and hydraulic oil (tramp oil).  
Some machines had their own MWF sumps, but most used one of four common 
sumps, the largest with a capacity >200,000 litres. Machined parts were 
washed with a mixture of water and detergent, which was recirculated. Some 
washers produced inhalable aerosols. 
 
In May 2004, we carried out an epidemiological investigation of the whole 
workforce, which had three aims:- 
• To measure the extent of the outbreak by identifying other workers who 
may have developed EAA or other work-related respiratory diseases. 
• To provide case-detection so that those affected can be treated.  
• To provide epidemiological data to identify the cause of the outbreak, so 
that appropriate remedial action could be taken. Specifically, to examine 
the association of MWF quality and MWF usage with work-related 
respiratory disease.  
This paper reports the results of the epidemiological investigation. A brief 
summary of the environmental investigation is given.   
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METHODS 
 
Clinical Investigation 
 
A three phase cross-sectional survey of the entire workforce was carried out to 
identify cases of respiratory disease. The payroll list from the Human Resources 
Department was used as the sample frame, which identified 832 current 
employees (33 subcontractors, 799 direct employees), and four index cases of 
alveolitis who were on sick leave, totalling 836 employees.  Employees were 
assigned by the workplace to one of 57 operational codes which in most cases 
were closely linked to a specific work area. 
 
(i) Phase I – Screening Questionnaire  
A short respiratory screening questionnaire (11 questions on respiratory and 
nasal symptoms) was distributed to the 836 employees in May 2004. Workers 
were asked to report symptoms present in the previous 18 months. Non-
responders were contacted twice more.  
 
(ii) Phase II – Factory Based Assessment  
In June 2004, those workers with one or more respiratory symptoms and/or 
weight loss on the screening questionnaire were invited for further assessment.  
A control group of 50 asymptomatic workers was selected randomly from the 
180 employees who declared no symptoms on the respiratory screening 
questionnaire. The selection of the controls was done using a random number 
table using the last 3 digits of their payroll number. 
 
The assessment consisted of:-  
 
Questionnaire  
A detailed self-completed questionnaire asked about demographic information, 
job history and clinical information (available on 
www.occupationalasthma.com/resources/outbreak_respiratory_survey.doc ). 
The questionnaire inquired whether symptoms were ‘better’, the ‘same’ or 
‘worse’ on ‘days away from work’ and ‘holidays’. Symptoms were classified as 
work-related if they improved on days off or on holiday. The month and year of 
first onset of each symptom was recorded.   
 
Spirometry  
Spirometry was measured on a wedge bellows spirometer (Vitalograph) 
according to ATS/ERS standards using ECCS predicted values.[19] 
 
Clinical Opinion 
Participants were seen by an experienced occupational respiratory physician; 
those with possible occupational asthma were asked to record serial 
measurements of peak expiratory flow (PEF), with subsequent clinical 
investigation depending on the result. Those with possible alveolitis or 
humidifier fever were offered full clinical investigation (phase III). 
 
Phlebotomy 
20ml blood was taken into two plain bottles, with the serum frozen, for later 
analysis for precipitins at the Health and Safety Laboratory, Sheffield. The 
results are reported separately by HSL.[20] 
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(iii) Phase III – Full Clinical Assessment 
 
Peak Flow Records 
Standard instructions for PEF records included 2-hourly measurements from 
waking to bedtime, on days at work and days away from work, for a total of 4 
weeks.[21] Records were analysed using Oasys-2 computing programme, 
which plots and analyses serial measurements of PEF for occupational effect. 
Oasys-2 works by discriminant analysis, scoring ‘complexes’ that are comprised 
of a work-rest-work pattern or a rest-work-rest pattern. Validation studies show 
that Oasys-2 has a sensitivity of  75% and a specificity of 94% for detecting 
occupational asthma.[22]  An Oasys score >2.67 and/or a mean day interpreted 
difference between work and rest days ≥16 l/min were defined as showing 
occupational asthma.[21][22] 
 
Clinical Investigation 
Workers selected in the previous phase were seen between November 2004 
and March 2005 by two occupational respiratory physicians. Investigations 
included lung function tests, including diffusion capacity (single breath Jaeger 
Masterscreen system 2), chest x-ray, and methacholine challenge (Yan 
method) for bronchial hyper-reactivity. Skin prick tests were performed for 
common environmental allergens with saline negative control, histamine 
positive control plus allergens - housedust, housedust mite, feathers, horse hair, 
cat dander, dog dander, mixed grasses, mixed tree pollens, plantain pollen, 
egg, milk, fish, wheat pollen, Cladosporium, Alternaria alternaria, Aspergillus 
fumigatus, Penicillium sp and Merulius lacrymans. Atopy was defined as at least 
one positive wheal (>3mm above saline control) to a common inhalable 
allergen. Lung volumes (helium dilution), HRCT scans and bronchoscopy were 
performed if indicated. A clinical diagnosis was made on the results of 
investigations and history. 
 
Case Definitions 
Case definitions for work-related respiratory diseases were agreed (Table 1), 
and applied to workers that had undergone further clinical investigations. Case 
definitions for EAA were adapted from Fox et al.[16]  Occupational asthma 
required a diagnostic PEF record [21][22] and humidifier fever was based on 
history (Table 1). We defined January 2003 as the onset date for the outbreak 
based on the presentation of the 12 index cases of EAA. 
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Table 1 – Case Definitions for Work-Related Respiratory Disease 
 
 
Disease 
 
 
Criteria for Case Definitions 
 
Extrinsic Allergic 
Alveolitis  
 
At least 4 of the 7 criteria 
must be met [16] 
 
Onset of disease after December 2002 and 
1. Physician diagnosis of EAA (probable or definite). 
2. Onset of at least 2 pulmonary symptoms (cough, 
wheeze, chest tightness, shortness of breath) and one 
systemic symptom (fever, weight loss) 
3. A history of symptoms improving regularly on days 
away from work and deteriorating on return to work. 
4. Restrictive pattern on spirometry – FVC <80% 
predicted and FEV1/FVC>70%   
5. Pulmonary diffusing capacity (TLCO) less than 80% 
predicted. 
6. Chest X ray or CT showing interstitial, reticulonodular 
or mosaic pattern. 
7. Biopsy evidence of non-caseating granulomas and/or 
lymphocytosis on bronchoalveolar lavage.  
 
Occupational Asthma 
 
 
Diagnostic PEF record in 2003-5 
(i.e. OASYS score > 2.67 and/or a mean day interpreted 
difference between work and rest days ≥16 l/min) [21] [22] 
 
Humidifier Fever 
 
      Onset of disease after December 2002 and a physician   
      diagnosis based on:- 
- Recurrent symptoms of a flu-like illness worst on 
first day of exposure after a break. 
- No weight loss or radiological infiltrates 
- No long term restrictive lung disease 
 
 
Specific Challenge Tests 
Two individuals, one with a pre-test diagnosis of EAA and one with occupational 
asthma and resolved humidifier fever had occupational-type bronchial 
provocation testing 6 months after removal from exposure.  Challenges to 
unused MWF used at the factory (a mixture of two products and water 
containing a number of chemicals including tolytriazole, ethanolamines, tall oil 
and boric acid) and used MWF taken from the largest common sump were 
performed on separate days. Initially, exposures were by a Pari Pot nebuliser 
with the aerosol directed generally into the challenge chamber for sequential 
periods of 10, 20 then 40 minutes (total exposure 70 minutes). Rest breaks 
occurred between challenges and any significant response would have 
terminated the challenge. Further challenges were made with the aerosol 
inhaled directly from the nebuliser using a mouthpiece for up to 17 minutes (2,5, 
and 10 minutes with breaks).   Spirometry was measured pre-challenge and 
regularly for at least 11 hours post challenge. A fall in FEV1 >15% from baseline 
was taken as a positive test.  
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Environmental Investigation 
 
Over the period of the outbreak, area and personal measurements of MWF in 
air were conducted using Health and Safety Executive (HSE) standard 
methodology, estimating total aerosol by extrapolating from the boron content of 
MWF.[23] Personal sampling was done over a 4 to 5 hour period. Common 
sumps were monitored for pH, concentration, tramp oil, bacteria and fungi.  
Smaller sumps were monitored for concentration and pH.  From November 
2003 sump samples were analysed for bacteria and fungi. 
 
 
Ethical Approval 
 
Ethical approval was not obtained as what is reported is the result of 
surveillance, and the investigation of surveillance failures, required by a legally 
binding improvement notice from the Health and Safety Executive. The 
surveillance was approved by both worker and management representatives. 
 
 
Analysis  
 
First, the onset (month and year) of work-related breathlessness reported in the 
Phase II questionnaire was plotted and related to the concentration of tramp oil 
in MWF.  Then, gender, ethnicity, smoking and use of MWF were compared for 
the affected and non-affected populations using chi-squared (with Yates 
continuity correction for 2x2 tables). Age and lung function were compared 
using t test and one-way analysis of variance.  Duration of employment was not 
normally distributed and so differences were analysed by Mann-Whitney U and  
Kruskal-Wallis test. 
 
The prevalence of work-related respiratory disease (alveolitis, asthma and 
humidifier fever) was calculated for the 57 operational codes, using the number 
working in each operational code as the denominator. The Fishers Exact test 
was used to compare the proportion with disease in a specific work location with 
the proportion of disease in the rest of the workforce.  Each code was also 
assigned into one of the following five groups: 
1. Machining, using MWF from a large common sump 
2. Machining, using MWF from a single or local sump 
3. Assembly and other manufacturing - working in the manufacturing area 
but not using MWF directly  (predominantly assembly jobs) 
4. Working all over the plant in the manufacturing area 
5. Working outside the main plant or in the office block 
 
Logistic regression was used to see if the occurrence of disease was different 
across these five location groups and obtaining an odds ratio, using the 4th 
group (working all over the plant) as the reference category. There was not 
enough disease in the 5th group (working outside the plant or in offices) for this 
to be used as the reference group.  Statistical analysis was done using SPSS 
(version 12).  
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RESULTS 
 
The workers investigated in the three phases of the study, and their diagnoses 
are shown in Figure 1.  
 
Phase I – Screening Questionnaire 
 
The screening questionnaire was completed by 808/836 (96.7%) workers. 481 
(60%) workers had at least one respiratory symptom, 147 (18%) had eye or 
nasal symptoms only and 180 (22%) were asymptomatic.  
 
   
Phase II – Factory Based Assessment 
 
454/481 (94.4%) of those with at least one respiratory symptom on the 
screening questionnaire and 48/50 (96%) asymptomatic ‘controls’ attended 
phase II. Table 2 shows their demographic characteristics. Those with 
respiratory symptoms, compared with asymptomatic controls, had lower lung 
function, more worked in manufacturing and more smoked.   
 
The detailed questionnaire showed that 146 employees had at least Grade 1 
MRC breathlessness, which was better on days away from work and/or on 
holiday (“work-related”) (Table 3).  Of these, 54/127 who gave a year when they 
first developed breathlessness had an onset in 2003 or later. Seventy workers 
defined the month when they first developed breathlessness - there were peaks 
in March and June 2003 (Figure 2). The prevalence of symptoms consistent 
with occupational bronchitis was 9.3%, work-related asthma 18.6% and 
humidifier fever 2.1% (Table 3).  
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Table 2 Characteristics of Employees with Respiratory Symptoms and the Asymptomatic Control Group who completed Phase 
II, and of those meeting the Case Definitions for EAA and OA in Phase III   
 
  i ii iii iv i vs iv ii vs iii vs iv  
  Respiratory 
Symptoms on 
Screening Q 
(n=454) 
Met Case 
Definition for 
EAA (n=19)1
Met Case 
Definition for OA 
(n=66)2
Controls 
(n=47) 
Statistical 
Difference 3
 
Statistical 
Difference 4
 
Age (years) Mean (SD) 44.7 (8.6) 47.5 (7.9) 43.4 (7.6) 43.6 (10.5) p=0.417 p=0.176 
Gender - Males       
               Females  
n (%) 
 
419 (92.2%) 
35 (7.8%) 
17 (89.5%) 
2  (10.5%) 
59 (89.4%) 
7 (10.6%) 
43 (91.5%) 
4 (8.5%) 
p=1.000 Not done 
Ethnicity- Caucasian   
          Non-caucasian 
n (%) 
 
396 (87.2%) 
58 (12.8%) 
18 (94.7%) 
1 (5.3%) 
53 (80.3%) 
13 (19.7%) 
44 (93.6%) 
3 (6.4%) 
p=0.298 p=0.064 
Smoking:-Current 
                  Ex 
                  Never  
n (%) 
 
125 (28%) 
127 (28%) 
197 (44%) 
3 (15.8%) 
7 (36.8%) 
9 (47.4%) 
15 (22.7%) 
18 (27.3%) 
33 (50%) 
6 (14.3%) 
13 (31.0%) 
23 (54.7%) 
p=0.086 
(current vs 
others) 
p=0.513  
(current vs 
others) 
FEV1 litres       
% predicted  
Mean (SD) 
Mean (SD) 
3.52 (0.76) 
96.8 (15.8)  
2.90 (0.66) 
83.4 (15.9) 
3.45 (0.69) 
94.9 (14.9) 
3.91 (0.76) 
102.8 (14.9) 
 
p=0.012 
 
p<0.001 
FVC    litres  
% predicted  
Mean (SD) 
Mean (SD) 
4.50  (0.93)  
103.5 (15.7)  
3.58 (0.74) 
85.1 (15.9) 
4.40 (0.86) 
101.4 (14.9) 
4.99 (0.98) 
110.0 (17.1) 
 
p=0.008 
 
p<0.001 
Works mostly in    
Manufacturing      
YES   n (%) 
No      n (%) 
368 (81%)  
 86 (19%) 
19 (100%) 
0   (0%) 
64 (97%) 
2 (3%) 
28 (60.9%) 
18 (39.1%) 
p=0.002 p<0.001 
Ever worked on     
machine with MWF  
YES   n (%) 
No      n (%) 
270 (60%) 
180 (40%) 
14 (73.7%) 
5 (26.3%) 
43 (65.2%) 
23 (34.8% 
22 (46.8%) 
25 (53.2%) 
p=0.111 p=0.06 
Duration of 
Employment at Factory 
(years) 
Median 
(Interquartile 
Range) 
10.5 (5 - 15) 9 (4 – 12) 12 (6 - 15) 9 (4 – 15)  p=0.403 p=0.306 
1 8 also had OA, 2 Excludes 8 with EAA,  3 Analysis by t test for age, FEV1 and FVC; Mann-Whitney U test for duration of employment.           
4 Analysis by one-way ANOVA for age, FEV1 and FVC; Kruskal-Wallis test for duration of employment.   3,4 Categorical data analysed by chi-
squared. 
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Table 3  Self-reported Work-Related Respiratory Symptoms at the 
Factory Assessment (Phase II)  
 
 Respiratory Symptoms on 
Screening Questionnaire 
(n=454).  
NB. Total workforce of 836 
used as denominator. 
Controls – asymptomatic on 
screening questionnaire 
(n=48) 
 Work-
related 
 
n (%) 
Not  
work-
related 
n (%) 
Total 
 
n (%) 
Work-
related 
 
n (%) 
Not  
work-
related 
n (%) 
Total 
 
n (%) 
MRC Breathlessness       
MRC1 – Troubled by shortness 
of breath when hurrying on 
level ground or walking up a 
slight hill. 
146  
(17.5%) 
77  
(9.2%) 
 
223  
(26.7%) 
2 
(4%) 
- 2 
(4%) 
MRC2 – Short of breath 
walking with other people of 
own age and sex on level 
ground. 
89  
(10.6%) 
41  
(4.9%) 
130  
(15.5%) 
1 
(2%) 
- 1 
(2%) 
MRC3 – Had to stop for breath 
when walking at own pace on 
level ground.  
41  
(4.9%) 
17  
(2%) 
58  
(6.9%) 
- - - 
MRC4 – Short of breath 
washing or dressing.  
16  
(1.9%) 
7  
(0.8%) 
23  
(2.7%) 
- - - 
MRC Chronic Bronchitis       
MRC chronic bronchitis – 
sputum production for 3 
months each year for 2 years 
or more 
78  
(9.3%) 
53  
(6.3%) 
131  
(15.6%) 
- - - 
Asthma Type Symptoms       
In last 12 months has your 
chest ever felt tight or your 
breathing become difficult ? 
156  
(18.6%) 
100  
(12.0%) 
256  
(30.6%) 
 
- 2  
(4%) 
2  
(4%) 
In the past 12 months have 
you had wheezing or whistling 
in your chest?  
122  
(14.6%) 
105  
(12.6%) 
227 
(27.2%) 
- 2  
(4%) 
2  
(4%) 
Humidifier Fever Type 
Symptoms 
      
In the past 12 months have 
you suffered recurrent flu like 
symptoms on 5 or more 
occasions?  
(Work-relatedness was defined 
as symptoms at the beginning 
of the working week, and/or 
being more frequent / severe 
on returning to work after a 
weekend or holiday.) 
18  
(2.1%) 
13  
(1.6%) 
31  
(3.7%) 
- - - 
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Phase III - Full Clinical Assessment  
 
173 employees were identified for full clinical investigation, as a result of either 
the factory assessment or the results of their PEF chart.  Of the 173, 162 
attended, 7 declined and 4 failed to attend. In total 198 workers completed PEF 
charts for analysis, this included 141 of the 162 who attended for clinical 
investigation and a further 57 employees who were not seen (as their results 
were negative).  Four controls were amongst those who completed PEF 
records.  Based on clinical opinion, 102 workers were diagnosed with probable 
or definite occupational lung disease, including 24 with EAA, 88 with 
occupational asthma, and 7 humidifier fever (some with more than one 
diagnosis). Additionally, there were 15 workers diagnosed with occupational 
bronchitis (defined by cough productive of sputum which was better away from 
exposure). There were also single cases of bronchopulmonary aspergillosis 
(diagnosed immunologically), lipoid pneumonitis and  Langerhans cell 
histiocytosis (both diagnosed from histology).  
 
 
Phase III - Numbers meeting the Case Definitions 
 
19 workers met the case definition for EAA (at least 4 of the 7 criteria) (Table 4). 
16 of these had the onset of symptoms after January 2003 (Table 4).  74 out of 
the 198 employees who returned PEF records, had a recording which met the 
case definition for occupational asthma (Table 4).  Half of these had first onset 
of asthma type symptoms since January 2003. Eight of these 74 met the EAA 
case definition as well.  Taking into account the overlap of disease, 87 
employees (10.4% of workforce) met case definitions for one or more of EAA, 
OA and HF (Figure 3). Thereafter, the analysis will refer to these 87 workers. 
 
Unexpectedly, a ‘control’ who was asymptomatic on the screening 
questionnaire was diagnosed as having occupational asthma, supported by a 
diagnostic PEF record (Figure 1). During clinical investigation he denied many 
symptoms. His spirometry was abnormal (FEV1 68%, FVC 74% predicted).   
 
Workers who met the case definition for EAA and OA were compared with the 
asymptomatic controls (Table 2). Those with EAA had restrictive disease with 
the lowest FEV1 and FVC, those with OA had obstructive spirometry (on 
average), and the controls had values above predicted as would be expected 
for a healthy worker population. There was no difference in the smoking history, 
demographics or in the length of exposure when defined by duration of 
employment, in the three groups. However, almost all of those with OA (97%) 
and all with EAA (100%) worked in the manufacturing areas which is 
significantly higher than the proportion in the control group (61%). Also, a higher 
proportion of EAA and OA cases had worked directly with MWF, compared with 
the controls.   
 
Skin tests for atopic status were performed on 13/19 workers with EAA and 
61/66 workers with OA. 3/13 (23%) with EAA and 33/61 (54%) with OA were 
atopic, showing the risk of OA to be associated with atopy. 
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Table 4  
Numbers with work related respiratory disease according to case 
definitions for EAA, Occupational Asthma and Humidifier Fever, with year 
of onset of symptoms, from Phase III 
  
 Met Case Definition 
Disease Symptoms 
pre 2003 
Symptoms 
2003 & 
onwards 
Total 
Occupational Asthma 37 37 74 
 
Humidifier Fever 1 6 
 
7 
Extrinsic Allergic Alveolitis   
Meeting at least 4 out of 7 Fox criteria 
 
3 16 19 
 
Numbers meeting each of the Fox Criteria for EAA [16] 
 
1) Physician diagnosis of EAA (probable or 
definite) (n=19) 
3 16 19 
2) Onset of at least 2 pulmonary symptoms 
(cough, wheeze, chest tightness, shortness of 
breath) and one systemic symptom (fever, 
weight loss)  (n=19) 
3 14 17 
3) A history of symptoms improving regularly 
on days away from work and deteriorating on 
return to work. (n=19) 
3 16 19 
4) Restrictive pattern on spirometry – FVC 
<80% predicted and FEV1/FVC>70% (n=19) 
1 3 4 
5) Pulmonary diffusing capacity (TLCO) less 
than 80% predicted (n=19) 
2 12 14 
6) Chest X ray or CT showing interstitial, 
reticulonodular or mosaic pattern  (n=19) 
2 13 15 
7) Biopsy evidence of non-caseating 
granulomas and/or lymphocytosis on 
bronchoalveolar lavage (n=16) 
1 8 9 
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Work Location of the 87 with Work Related Respiratory Disease (Phase III) 
 
The 87 workers with disease were distributed across 22 work locations in the 
factory (Figure 4), with no workers with disease in 35 other work locations (as 
defined by their operational codes). Geographically, the cases of disease were 
clustered at the northern end of the factory. The work location with the highest 
number of cases was an engine assembly area (Assembly 1), but also had the 
largest number of employees.  As the numbers working in each location varies, 
the prevalence of disease is shown in Figure 5. Four work locations all involved 
in machining (Machining 1,2,3 and 5) had a significantly higher rate of disease 
compared with the rest of the factory (Figure 5).  These four work locations 
were all in the northern half of the factory served directly by the largest common 
MWF sump (200,000 litres) or directly adjacent to it.   A map of the factory 
showing the prevalence of disease for the work locations, along with the 
location of the four main sumps and two washers shown to generate mist, is 
given in the on-line depository (Map 1).   
 
Table 5 shows the distribution of cases across the five work location groups 
(see Map 2 in the on-line depository for the location of these five areas within 
the factory). Working in machining using MWF from the largest common sump 
was associated with over 4 times increased risk of having disease (27.3%) than 
workers who worked all over the manufacturing area (7.9%) (OR 4.39, 95% CI 
2.00 – 9.60). Further analysis by type of disease showed that machining using 
MWF from the large sump significantly increased the odds of developing 
occupational asthma (OR 4.36, 95% CI 1.69 – 11.24), although elevated this 
was not statistically significant for EAA (OR 2.62, 95% CI 0.73 - 9.38). 
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Table 5  Percentage of Workers with Work Related Respiratory Disease (meeting the case definition) by Grouped Work Location, 
along with the Odds Ratio (OR) of disease across the work locations (Phase III) (denominators are total population in each work 
location) 
 
  Met Case Definition for EAA, OA and/or 
HF 
 
Met Case Definition for EAA 
(8 also have OA)  
 
Met Case Definition for OA 
 
  
Work Location Total 
population 
(n) 
n % Odds Ratio 
(95% CI) 
compared with 
‘works all over’ 
 
n % Odds Ratio 
(95% CI)  
compared with 
‘works all over’ 
 
n % Odds Ratio 
(95% CI) 
compared with 
‘works all over’ 
 
1.  Machining, using 
large MWF Sump  
66 18 27.3% 
 
4.39 
(2.00 to 9.60) 
p<0.001 
5 7.6% 2.62 
(0.73 to 9.38) 
p=0.138 
12 18.2% 4.36  
(1.69 – 11.24) 
p=0.002 
2.  Machining, using 
single/local MWF 
sumps 
150 19 12.7% 
 
1.70 
(0.81 to 3.57) 
p=0.164 
2 1.3% 0.43 
(0.08 to 2.26) 
p=0.321 
16 10.7% 2.34  
(0.97 – 5.65) 
p=0.058 
3. Assembly & other 
manufacturing 
320 36 11.3%  
 
1.48  
(0.76 to 2.88) 
p=0.246 
7 2.2% 0.72 
(0.22 to 2.29) 
p=0.573 
29 9.1% 1.96 
(0.87 – 4.38) 
p=0.103 
4. Works all over 
plant 
165 13 7.9% 
 
1 5 3.0% 1 8 4.8% 1 
5. Outside / Office 
building 
135 1 0.7% 
 
 0 0%  1 0.7%  
Total 836 87 10.4% 
 
 19 2.3%  66 7.9%  
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Challenge Results 
 
Of the two workers challenged, the worker with alveolitis had a late reaction to 
used MWF with a 14.6% fall in FEV1 following indirect exposure and a 22% 
fall after direct exposure, with <1% change following unused MWF exposure. 
He had normal methacholine reactivity throughout. The worker with 
occupational asthma had a borderline reaction to the indirect exposure 
(immediate 13.7%, late 11.2% with a lower FEV1 the following morning) and a 
significant dual asthmatic reaction with direct exposure (immediate 21.7%, 
late 13%) (Figure 6). His methacholine reactivity deteriorated from 2400ug 
(normal >2000ug) pre challenge to 300ug the day after the positive challenge. 
 
  
Environmental Results 
 
Results of air monitoring between May 2002 and October 2003 showed that 
concentrations of MWF in air were generally below the then HSE guidance 
value of 1mg/m3.[23]  In October 2003, levels of mineral oil mist in air were 
between 1 and 4 mg/m3 with an average concentration of just above 1 mg/m3, 
also generally below the exposure guidance value of 3 mg/m3.[24]   Personal 
samples of mineral oil mist taken at the same time indicated exposures of 
between 1 – 1.7 mg/m3, with an average exposure of 1.3 mg/m3.   
 
Samples of MWF taken from the largest common sump in August 2004 
showed no bacterial, mycobacterial or fungal growth, with no increased 
endotoxin levels. DNA extraction identified Acinetobacter sp and Ochrobacter 
anthropi, but no Mycobacterium sp.  Acinetobacter sp  and Ochrobacter 
anthropi were grown from washing machines.[20]  
 
Factory records showed a steep rise in tramp oil in the MWF in the large 
communal sump around April 2003, just after the hydraulic oil used in 
machines was changed (Figure 2).  A complicating factor was that March 
2003 was reported by the highest number of workers for their onset of 
breathlessness, just before the tramp oil increased.  
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DISCUSSION 
 
The current investigation of employees in a car manufacturing plant in the UK 
detected 19 workers with EAA according to a strict case definition. During the 
investigation we also uncovered a large unknown outbreak of occupational 
asthma, with 74 workers diagnosed on the basis of serial peak flow records, 
which are both reasonably sensitive and very specific for identifying patients 
with occupational asthma.[21] [22] [25]   In total 87 workers met case 
definitions for occupational asthma and/or EAA and/or humidifier fever, an 
overall prevalence in the workforce of 10%.  Half of the workers with 
occupational asthma had symptoms pre 2003 (the date for new onset was 
defined as January 2003 or later based on the 12 index cases of EAA), 
suggesting that the outbreak of occupational asthma may have begun earlier 
than the outbreak of alveolitis.   
 
We also identified workers with humidifier fever and work-related chronic 
bronchitis, as well as single cases of histiologically confirmed lipoid 
pneumonitis and  Langerhans cell histiocytosis, and immunologically 
confirmed bronchopulmonary aspergillosis.  The variety of different 
presentations of work-related respiratory disease related to exposure to MWF 
in the current study is consistent with other outbreaks of EAA in the USA.  
Zacharisen et al reported cases of EAA, asthma and bronchitis in a car engine 
manufacturing plant.[26]  Hodgson et al found that many workers with EAA 
also had asthma, and there was at least one case of usual interstitial 
pneumonia and a case of sarcoidosis at the plant which produced titanium 
and steel parts for the aerospace industry.[17]  Similarly, in the present 
investigation 8 of the 19 workers who met the case definition for EAA also had 
peak flow variability consistent with the case definition for OA. EAA can 
produce findings of airways obstruction on spirometry, possibly due to 
associated bronchiolitis. It is conceivable that such airways obstruction would 
also show a work-related pattern.  
 
Before further interpreting the results, it is important that the methodological 
limitations are discussed.  Firstly, with 87 cases of work-related respiratory 
disease observed at the factory the size of the control group (50) may  seem 
rather low. The number of controls had to be decided at the start of the 
investigation, as the data collection had to happen for all at the same time, 
before the remedial action at the factory commenced. At that time the number 
of known (index) cases of EAA was only 12, and we were unaware of any 
cases of OA therefore the sample size of 50 controls was thought to be 
reasonable.  Secondly, a lower proportion of the control group worked in the 
manufacturing area compared with the cases of OA and EAA, and as a 
consequence they had less potential to be exposed to MWF.  This was due to 
the control population being selected from the asymptomatic workers 
identified from the screening questionnaire.  The selection bias in the control 
group probably doesn’t affect the results presented in this paper, as the focus 
of the paper is more about the epidemiology of those with respiratory illness. 
The results from this control group does reaffirm that working in the 
manufacturing area is associated with an increased risk of disease. 
 
Another methodological issue is that the date of onset of symptoms was 
established retrospectively from the self-completed questionnaire, more than 
15 months after the onset of the outbreak. Only 70 out of the 146 workers with 
work-related breathlessness were able to identify the month of onset. There 
 on 14 October 2008 thorax.bmj.comDownloaded from 
 17
was no contemporary surveillance data. With these caveats there appears to 
be a peak incidence in March 2003, just before a new hydraulic oil for metal 
working machines was introduced in April 2003. The new hydraulic oil was 
more soluble in the MWF, increasing the concentration of tramp oil in the 
MWF. However, as the change in hydraulic oil occurred after the start of the 
outbreak, there is no clear evidence that this change is significant. The 
outbreak also coincided with reports of increased misting in the factory during 
the winter period when the roof louvers were closed.  
 
Although factory records historically showed little bactierial growth, our own 
microbiological investigations in the factory found Acinetobacter sp and 
Ochrabactrum anthropi cultured from the washer fluid.  DNA from these 
bacteria were also identified in the MWF from the largest sump although there 
was no culture. No Mycobacterium sp were identified either from culture or 
from DNA extraction.  The Health and Safety laboratory have carried out a 
parallel immunological investigation of the workers at the factory in the current 
investigation, which is reported in detail elsewhere.[20] MWF from the largest 
common sump at the time of the outbreak, and extracts from cultures of 
Acinetobacter sp, Ochrobactrum anthropi and Mycobacterium sp, were used 
to look for the presence of precipitating antibodies.[20] In those with EAA, 
59% had precipitating antibodies to at least one of the microbial species, 
Acinetobacter or Ochrobactrum, or to used sump oil, whereas precipitating 
antibodies were found in only 10% of those with OA, and 5% of asymptomatic 
workers (controls).[20]   This is unlike other outbreaks of alveolitis where 
precipitating antibodies are commonly found in affected and asymptomatic 
subjects.[27] No workers tested positive for precipitating antibodies to 
Mycobacteria species. These results indicate that bacterial contamination of 
MWF, and in particular Acinetobacter, had at least a contributory role in the 
cases of EAA.   
 
The overall levels of mist, from both MWF and mineral oil sources, were 
unremarkable, with most levels below the then MWF guidance value of 
1mg/m3 and the mineral oil in air guidance value of 3mg/m3.[23] [24]   The 
HSE (UK regulatory body for health and safety) has since withdrawn these 
guidance values.[28]   
 
The highest number of cases was in one of the assembly areas which was 
about 30 metres from the common sump, suggesting that the causative 
aerosol was relatively widespread. Two washers vented inside the factory and 
were also in the northern end of the factory. Given the wide distribution of 
disease in the factory the most likely cause was an aerosol  from either the 
metalworking and / or  washing operations, although no material within this 
mist has been confirmed as a specific causal agent.    
 
The potential of  other exposure  factors as a cause of this outbreak were 
considered. Metal particles can produce an intra-pulmonary inflammatory 
response,[29] and some  specific metals are well recognized causes of 
occupational asthma. These are mainly platinum salts, chrome and cobalt, 
and to a lesser extent zinc and nickel.  At the factory the engines were made 
of aluminium alloy. There was no platinum, chrome or nickel. There was one 
machine where hard metal valve rings were machined. Cobalt levels in the 
MWF were insignificant and  levels were checked in the urine of workers and 
were normal. There is some doubt as to whether aluminium alone can cause 
occupational asthma. The main work on aluminium and asthma comes from 
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smelters where aluminium sodium fluoride is a possible cause. It has never 
been described in those working with cold aluminium.  There were no sources 
of NOX (no heating of the metal).  However, the potential for other chemical 
constituents to be either causal or to have had a co-effect cannot be 
discounted. The HSE has compiled a list of the constituents and contaminants 
of the MWF and wash fluids at the factory which were considered in the 
original investigation as possible causes of either EAA or OA (available in the 
online appendix).  
 
During bronchial challenge tests, two workers (one with OA and one with 
EAA) confirmed reactions to the used MWF taken from the common sump but 
not the clean MWF. The used MWF will contain material from the aluminium 
alloy castings, microbial contamination and added biocides, pH adjusters etc.  
The lack of reaction to the unused MWF indicates that the chemical 
constituents alone  were unlikely to have caused the disease.    
 
As a consequence of this outbreak UK policy has changed,  firstly for the 
users of  MWF and secondly for those affected by EAA. 
Firstly,  the ‘lessons learned’  from this outbreak have been  published by the 
Health and Safety Executive on their website (this is available for the web-
based Appendix), detailing the practical implications for other users of 
MWF.[28] This outbreak showed that adhering to the guidance standards of 
oil mist did not prevent respiratory disease, [23] [24] and has led to their 
withdrawal by the HSE. Furthermore, the HSE have since issued new 
guidance on safe working practices that includes a requirement for respiratory 
surveillance. The HSE has subsequently carried out a national survey of large 
users of MWF in 2005/2006 to identify the extent to which guidance was being 
followed, with many deficiencies noted.[30]  
 
Secondly, there is an anomaly in that occupational asthma due to oil mists is 
compensatable in the UK through a no-fault compensation system from the 
UK Government’s  Department for Work and Pensions, however  EAA due to 
anything other than fungal or avian antigens, is not.[31]  Occupational asthma 
is known to adversely affect income and clinical outcome,[32] [33] whereas 
the impact of EAA  is likely to be at least as important.  In July 2006, the 
Industrial Injuries Advisory Council (who advise the Department of Work and 
Pensions of the list of prescribed diseases for compensation) recommended 
that the occupational coverage for EAA should include exposure to mists from 
MWF.[34] At the time of writing, this is awaiting ministerial approval, and not 
yet added to the list of prescribed diseases.[31]  
 
Finally, it is of interest to note what happened after the outbreak at the factory. 
After the assessment at the factory in June 2004, a series of control measures 
were introduced, including:[28]   
• replacing  MWF in the large common sumps, 
• cleaning machines with individual sumps (both metalworking and 
washing) which were heavily contaminated with bacteria, and then 
refilling them with fresh fluid 
• treating other less contaminated sumps with biocide, 
• supplying employees with respiratory protection, with powered 
respirators for those with known disease, and 
• instituting respiratory surveillance for all employees. 
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Continued surveillance using occupational PEF records was carried out for 
those with OA, and a few had persistent OA despite the extensive control 
measures. The factory went into administration in April 2005. The machinery 
was subsequently bought by Nanjing Automobile (Group) Corporation and 
removed to China. Nanjing have been warned about the risks. 
 
Conclusions 
This investigation of an outbreak of EAA in a car manufacturing plant detected 
a large number of affected workers, not only EAA but also occupational 
asthma, and is the largest reported outbreak in Europe. Mist from used MWF 
is the likely cause, yet oil mist was generally below guidance values, 
emphasising that it was time to reconsider the standards and issue new 
guidelines.  Our study suggests that in workplaces using MWF and wash 
fluids, there is a need to carry out risk assessments, ensure that fluid quality is 
monitored and maintained, improve the control of mist and carry out 
respiratory health surveillance on exposed workers. 
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Figure Headings 
 
Figure 1  Diagram showing participation in the three phases of the 
investigation and diagnoses following the clinical investigations 
 
Figure 2  Onset of work-related breathlessness from Phase II questionnaire 
(bars), in relation to the peak monthly tramp oil levels in MWF (line) 
 
Figure 3  Case Defined Work Related Respiratory Disease (n=87), showing 
overlap of disease, at Phase III 
 
Figure 4   87 Workers with Work Related Respiratory Disease by Work 
Location and disease  
 
Figure 5   Percentage (95% confidence intervals) of Workers with Work 
Related Respiratory Disease by Work Location (* p<0.05, **p<0.01 denotes 
work location higher than rest of workforce) 
 
Figure 6  Bronchial provocation challenge test with unused and used MWF, on 
a worker with occupational asthma
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Figure 1 - Diagram showing participation in the three phases of 
the investigation and diagnoses following the clinical 
investigations
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Figure 2  Onset of work-related breathlessness from Phase II questionnaire (bars), in relation to the peak monthly tramp 
oil levels in MWF (line)
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Figure 3 – Case Defined Work Related Respiratory 
Disease (n=87), showing overlap of disease, at Phase III
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Figure 4 - 87 Workers with Work Related Respiratory 
Disease by Work Location and disease
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Figure 5 - Percentage (95% confidence intervals) of Workers with 
Work Related Respiratory Disease by Work Location (* p<0.05, 
**p<0.01 – denotes significantly higher than rest of workforce)
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Figure 6  Bronchial provocation challenge test with unused and 
used MWF, on a worker with occupational asthma
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